I'm going to go out on a limb and say they will have circa 900 on Daybue (appx 70M Q3 sales). no way Acadia world spend $100M upfront plus who knows how much to get through to international sales, if the new patient uptake rate plateaued in Q1. With access getting better (more coverage) and good feedback from the Rett community, I wouldn't be surprised if the uptake rate per month resembled a bell curve.
Ann: Neuren and Acadia expand global partnership for trofinetide, page-154
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.47 |
Change
-1.120(7.18%) |
Mkt cap ! $1.849B | |||
| Open | High | Low | Value | Volume |
| $15.38 | $15.40 | $14.40 | $9.160M | 624.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50 | $14.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.55 | 1764 | 2 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |